mRNA prototype from CNBG at a Scientific and Technological Innovation Exhibition in China | Source: New York Times September 14, 2022 | Nandika Nair, 2022 Summer Intern, Bridge Consulting In this article, we touch upon: The advancement in China’s vaccine R&D over time and after the COVID-19 outbreak The development of Chinese vaccines based on more […]
A staff member of Sinopharm is handling the test vaccine samples | Source: China Daily September 6, 2022 | By Zoe Leung, Associate; Stefania Jiang, Junior Associate, Bridge Consulting What Happened? On 23 August 2022, the World Health Organization (WHO) announced that China’s National Regulatory Authority (NRA) for vaccines had reached a functional maturity level […]
Families lining up to receive the “sugar pill” | Source: CGTN
Source: Xinhua May 27, 2022 | By Cheng Wei Jian, 2022 Spring Intern, Bridge Consulting At the 75th World Health Assembly in May 2022, one of the key messages in the area of global pandemic preparedness was the need to diversify vaccine manufacturing across emerging economies. Cooperation in the development of vaccines has become all the […]
March 22, 2022 | By Zoe Leung, Associate, Bridge Consulting | Image Source: AFP Less than two years ago, President Xi Jinping announced China’s commitment to developing COVID-19 vaccines for the world. China was not only promising greater engagement in global health affairs, but it was also anticipating that its vaccine industry could step up […]